Castle Creek Arbitrage’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-135,426
Closed -$12.2K 41
2023
Q3
$12.2K Sell
135,426
-80,000
-37% -$10.7K ﹤0.01% 168
2023
Q2
$32.9K Hold
215,426
﹤0.01% 200
2023
Q1
$23.2K Hold
215,426
﹤0.01% 280
2022
Q4
$28.8K Hold
215,426
﹤0.01% 304
2022
Q3
$41K Hold
215,426
﹤0.01% 449
2022
Q2
$62K Hold
215,426
﹤0.01% 433
2022
Q1
$174K Hold
215,426
0.01% 428
2021
Q4
$408K Hold
215,426
0.02% 397
2021
Q3
$573K Hold
215,426
0.03% 313
2021
Q2
$579K Hold
215,426
0.03% 351
2021
Q1
$558K Buy
+215,426
New +$623K 0.03% 318

Other funds holding NUVB.WS

Castle Creek Arbitrage's NUVB.WS Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q4 2023, closing a stake of 135,426 shares — an estimated $12.2K sold.

Castle Creek Arbitrage first reported a position in NUVB.WS in Q1 2021 and held it in 11 quarters. The position peaked at $579K in Q2 2021. 17 funds tracked by Wall St. Rank hold NUVB.WS as of Q4 2023.

  • Castle Creek Arbitrage reported no remaining Nuvation Bio Inc Warrants position as of Q4 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 135,426 Nuvation Bio Inc Warrants shares in Q4 2023, an estimated $12.2K.
  • Castle Creek Arbitrage first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 11 quarters.
  • Castle Creek Arbitrage's Nuvation Bio Inc Warrants position peaked at $579K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.